Working Group

Commercial Payer Council

Overview

Facilitated by MDIC’s Health Economics and Patient Value (HEPV) program, the Commercial Payer Council serves as a neutral platform for critical conversations, drawing together visionaries from various sectors including integrated healthcare delivery networks, payers, device companies, health plans, health technology assessment organizations, law firms and consultants in health policy, market access, and reimbursement.

Get Involved

For further information regarding the MDIC Commercial Payer Council and how to get involved, interested parties are encouraged to reach out to Harry Kotlarz, Vice President of HEPV, via email at hkotlarz@mdic.org.

FEATURED CONTENT

The GLP-1 Revolution and Its Impact on the MedTech Industry

Senior medical officers, reimbursement strategists, and industry experts examine the opportunities and challenges that GLP-1 drugs pose for payers, medical device companies, and patients.

Download

Download Key Insights from the Commercial Payer Council

Commercial Payer Council: Q2 Key Insights

Key Insights: MDIC Commercial Payer Council Q1 2024

The Impact of GLP-1s on the MedTech Industry: MDIC Commercial Payer Council